• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Projects
  • Funding
  • Research Data
  • Organizations
  • Researchers
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Potent neutralization by monoclonal human IgM against SARS-CoV-2 is impaired by class switch.
 

Potent neutralization by monoclonal human IgM against SARS-CoV-2 is impaired by class switch.

Options
  • Details
BORIS DOI
10.48350/170032
Date of Publication
July 5, 2022
Publication Type
Article
Division/Institute

Institut für Virologi...

Contributor
Callegari, Ilaria
Schneider, Mika
Berloffa, Giuliano
Mühlethaler, Tobias
Holdermann, Sebastian
Galli, Edoardo
Roloff, Tim
Boss, Renate
Infanti, Laura
Khanna, Nina
Egli, Adrian
Buser, Andreas
Zimmer, Gert
Institut für Virologie und Immunologie (IVI)
Derfuss, Tobias
Sanderson, Nicholas S R
Subject(s)

600 - Technology::630...

Series
EMBO reports
ISSN or ISBN (if monograph)
1469-3178
Publisher
EMBO press
Language
English
Publisher DOI
10.15252/embr.202153956
PubMed ID
35548920
Uncontrolled Keywords

B cells MACACS antibo...

Description
To investigate the class-dependent properties of anti-viral IgM antibodies, we use membrane antigen capture activated cell sorting to isolate spike-protein-specific B cells from donors recently infected with SARS-CoV-2, allowing production of recombinant antibodies. We isolate 20, spike-protein-specific antibodies of classes IgM, IgG, and IgA, none of which shows any antigen-independent binding to human cells. Two antibodies of class IgM mediate virus neutralization at picomolar concentrations, but this potency is lost following artificial switch to IgG. Although, as expected, the IgG versions of the antibodies appear to have lower avidity than their IgM parents, this is not sufficient to explain the loss of potency.
Handle
https://boris-portal.unibe.ch/handle/20.500.12422/85083
Show full item
File(s)
FileFile TypeFormatSizeLicensePublisher/Copright statementContent
EMBO_Reports_-_2022_-_Callegari_-_Potent_neutralization_by_monoclonal_human_IgM_against_SARS_CoV_2_is_impaired_by_class.pdftextAdobe PDF1.28 MBAttribution (CC BY 4.0)publishedOpen
BORIS Portal
Bern Open Repository and Information System
Build: 27ad28 [15.10. 15:21]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo